Initiation and promotion in experimental oral carcinogenesis

Area of Science:

• Oncology
• Carcinogenesis Research
• Chemical Carcinogenesis

Background:

• 7,12-dimethylbenz(a)anthracene (DMBA) is a known carcinogen.
• The role of promoting agents in carcinogenesis requires further investigation.
• Benzoyl peroxide and its solvent are generally considered non-carcinogenic.

Purpose of the Study:

• To investigate the potential of a subthreshold dose of DMBA to induce carcinoma.
• To determine if a non-carcinogenic promoting agent, benzoyl peroxide, can facilitate tumor development after DMBA exposure.
• To evaluate the carcinogenic potential of combined DMBA and benzoyl peroxide treatment in a hamster model.

Main Methods:

• Syrian hamsters were administered a subthreshold dose of 0.1% DMBA in oil.
• Following DMBA exposure, hamsters received a period of no treatment, then treatment with 40% benzoyl peroxide.
• Carcinoma development was monitored over 25 weeks.
• Appropriate control groups were included.

Main Results:

• Subthreshold DMBA treatment alone did not induce carcinoma within 25 weeks.
• DMBA treatment followed by benzoyl peroxide administration resulted in rapid carcinoma development.
• The observed tumor development highlights a synergistic effect between DMBA and benzoyl peroxide.

Conclusions:

• A subthreshold dose of DMBA is insufficient to initiate carcinogenesis on its own.
• Benzoyl peroxide can act as a potent tumor promoter, facilitating rapid carcinoma development in the presence of prior DMBA exposure.
• This study demonstrates a two-stage carcinogenesis model involving initiation and promotion.